Key Finding: Single protein discovery could unlock CAR-T cell therapy’s full potential

Last updated: 20/06/2026 08:51

0 Min Read

Researchers identify NFIL3 protein as key barrier to CAR-T cell therapy success. Disabling this protein maintained stronger cancer-fighting activity in preclinical models. — Photo: turek / Pexels

1 min read|32 words

⚡ KEY FINDING: Disabling NFIL3 protein prevented CAR-T cell exhaustion and maintained stronger anti-tumor activity in animal models. Could this be the breakthrough cancer patients need?

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Single protein discovery could unlock CAR-T cell therapy’s full potential →

Share This Article

ByProf. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Key Finding: Single protein discovery could unlock CAR-T cell therapy’s full potential

Submit Your Paper →

Whey protein triggers substantial insulin response despite low carbohydrate content, research shows

What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

UK childhood vaccination coverage holds steady at high levels, latest quarterly data shows

Submit Your Paper to GMJ

Company

You Might Also Like